Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 908581-18-0 | MDL No. : | MFCD13195317 |
Formula : | C9H7BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HVNRXVYXTRSZKM-UHFFFAOYSA-N |
M.W : | 255.07 | Pubchem ID : | 57362633 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 54.17 |
TPSA : | 43.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.22 cm/s |
Log Po/w (iLOGP) : | 2.09 |
Log Po/w (XLOGP3) : | 2.31 |
Log Po/w (WLOGP) : | 1.88 |
Log Po/w (MLOGP) : | 1.35 |
Log Po/w (SILICOS-IT) : | 1.43 |
Consensus Log Po/w : | 1.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.22 |
Solubility : | 0.154 mg/ml ; 0.000602 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.86 |
Solubility : | 0.349 mg/ml ; 0.00137 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.02 |
Solubility : | 0.244 mg/ml ; 0.000957 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 903129-78-2 ]
6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid
Similarity: 0.94
[ 603311-76-8 ]
Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate
Similarity: 0.75
[ 50735-34-7 ]
Methyl 2-amino-5-bromopyridine-3-carboxylate
Similarity: 0.75
[ 217435-65-9 ]
6-Bromo-8-methylimidazo[1,2-a]pyridine
Similarity: 0.74
[ 1042141-37-6 ]
Methyl 2-bromoimidazo[1,2-a]pyridine-6-carboxylate
Similarity: 0.73
[ 133427-07-3 ]
Methyl imidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.91
[ 760144-55-6 ]
Methyl 6-chloroimidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.82
[ 1262409-63-1 ]
Ethyl 3-iodoimidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.78
[ 603311-76-8 ]
Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate
Similarity: 0.75
[ 50735-34-7 ]
Methyl 2-amino-5-bromopyridine-3-carboxylate
Similarity: 0.75
[ 903129-78-2 ]
6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid
Similarity: 0.94
[ 133427-07-3 ]
Methyl imidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.91
[ 133427-08-4 ]
Imidazo[1,2-a]pyridine-8-carboxylic acid
Similarity: 0.85
[ 760144-55-6 ]
Methyl 6-chloroimidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.82
[ 1262409-63-1 ]
Ethyl 3-iodoimidazo[1,2-a]pyridine-8-carboxylate
Similarity: 0.78